Invention Grant
- Patent Title: Treatment of cancer using TLR3 agonists
- Patent Title (中): 使用TLR3激动剂治疗癌症
-
Application No.: US12787832Application Date: 2010-05-26
-
Publication No.: US08409813B2Publication Date: 2013-04-02
- Inventor: Fabrice Andre , Laurence Zitvogel , Jean-Christophe Sabourin
- Applicant: Fabrice Andre , Laurence Zitvogel , Jean-Christophe Sabourin
- Applicant Address: FR Villejuif, Cedex
- Assignee: Institut Gustave Roussy
- Current Assignee: Institut Gustave Roussy
- Current Assignee Address: FR Villejuif, Cedex
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Main IPC: G01N33/53
- IPC: G01N33/53 ; A61K48/00
Abstract:
The present invention relates generally to the fields of genetics and medicine. More specifically, the present invention relates to improved methods of treating cancers using a TLR3 agonist, by assessing the expression of a TLR3 receptor by cancer cells.
Public/Granted literature
- US20100266680A1 Treatment of Cancer Using TLR3 Agonists Public/Granted day:2010-10-21
Information query
IPC分类:
